Loading organizations...
Loading organizations...
Developing medicines for liver disease treatment.
Hepagene Therapeutics has raised $40.0M across 1 funding round.
Hepagene Therapeutics has raised $40.0M in total across 1 funding round.
Hepagene Therapeutics has raised $40.0M in total across 1 funding round.
Hepagene Therapeutics's investors include Loyal Valley Capital, Apricot Capital, Oceanpine Capital.
Hepagene Therapeutics has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series B in April 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 26, 2021 | $40.0M Series B | Loyal Valley Capital | Apricot Capital, Oceanpine Capital |